Ignite Creation Date:
2025-12-24 @ 5:34 PM
Ignite Modification Date:
2026-05-19 @ 7:06 AM
Study NCT ID:
NCT00220168
Status:
COMPLETED
Last Update Posted:
2009-12-16
First Post:
2005-09-19
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase II Trial Evaluating Irinotecan and Capecitabine Relapsed/Refractory Upper GI Tumours
Sponsor:
Royal Marsden NHS Foundation Trust
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Upper Gastrointestinal Tumours | View |
Keywords: